Novel Computational Pathology-Based Trop2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer in Tropion-Lung01 Phase 3 Trial
基於新型計算病理學的Trop2生物標誌物對Tropion-Lung01第3期試驗中非小細胞肺癌患者的丹託帕替珠單抗治療的臨床結果具有預測意義